Effects of a Thermal Spa Short Residential Program for Prevention of Work-related Stress / Burn-out on Biomarkers of Stress - A Proof of Concept Study (ThermStress)

May 14, 2018 updated by: University Hospital, Clermont-Ferrand

Work-related stress is a public health issue. Among the multiple physical and psychological consequences of stress, increased mortality and cardiovascular morbidity seem the main concern. The thermal spa resort of Néris-Les-Bains is one of the five spa resorts in France specialized in the treatment of psychosomatic disorders. Among all these resorts proposing a thermal residential program of three weeks, only one thermal spa resort (Saujon) has a program for occupational burn-out. However, a shorter thermal spa residential program seems more compatible with professional context (availability of individuals), and focusing on work-related stress prevention (before the state of burn-out).

The main hypothesis is that a short thermal spa residential program (6 days) of work-related stress prevention will exhibit its efficacy through objective measures of well-being and cardiovascular morbidity.

Study Overview

Status

Unknown

Detailed Description

The Therm-Stress protocol was designed to provide a better understanding of the effect of a short spa residential program of work-related stress prevention on the improvement of heart rate variability.

In the present protocol, parameters are measured on six occasions (inclusion, 6 days before the start, at the start of the spa, at the end of the spa, at 6 months and at 12 months).

Statistical analysis will be performed using Stata software (version 13; Stata-Corp, College Station, Tex., USA). All statistical tests will be two-sided and p<0.05 will be considered significant. After testing for normal distribution (Shapiro-Wilk test), data will be treated either by parametric or non-parametric analyses according to statistical assumptions. Inter-groups comparisons will systematically be performed 1) without adjustment and 2) adjusting on factors liable to be biased between groups.

Analysis will be performed using anova or Kruskal-Wallis (KW) tests. When appropriate (p<0.05), a post-hoc test for multiple comparisons (Tukey-Kramer after anova and Dunn post KW) will be used. Linear regression (with logarithmic transformation if necessary) considering an adjustment on covariates fixed according to epidemiological relevance and observance to physical activity will complete the analysis.

Comparisons of categorical variables will be performed using Chi-squared or Fischer test. Marascuillo's procedure will be performed for multiple comparisons. Relations between quantitative outcomes will be analyzed using correlation coefficients (Pearson or Spearman). Fisher's Z transformation and William's T2 statistic will be performed to compare correlations between variables and within a single group of subjects. Longitudinal data will be treated using mixt-model analyses in order to treat fixed effects group, time and group x time interaction taking into account between and within participant variability.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France, 63003
        • Recruiting
        • Chu Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Workers with a visual analog scale of stress greater than 50 mm
  • from 18 years to retirement
  • written informed consent
  • Affiliation to French health care system (for France)

Exclusion Criteria:

  • Participant refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Experimental group

Participants will be involved in a short-term spa residential program of 6 days combining psychological intervention, physical activity, thermal spa treatment, health education and corrections of eating disorders.

After the program, participants will be followed for 12 months.

6 days spa residential program combining psychological intervention, physical activity, thermal spa treatment, health education and corrections of eating disorders.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
heart rate variability
Time Frame: at inclusion (Month1 to Month5)

To assess the ability of a short spa residential program of management of work-related stress in increasing heart rate variability, a biomarker of both stress and morbidity/mortality.

Heart rate variability will be measured by zephyr during 26h recording time

at inclusion (Month1 to Month5)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variation of biomarkers of stress after the end of the interventional phase.
Time Frame: at inclusion (Month1 to Month5)
Evaluate the effectiveness of an individualized thermal intervention on biomarkers of stress among working people.
at inclusion (Month1 to Month5)
Variation of cardiovascular risk after the end of the interventional phase.
Time Frame: at inclusion (Month1 to Month5)
Evaluate the effectiveness of an individualized thermal intervention on cardiovascular risk among working people.
at inclusion (Month1 to Month5)
Genetic polymorphisms related to stress
Time Frame: at inclusion (Month1 to Month5)
effectiveness of an individualized thermal intervention on genetic polymorphisms related to stress.
at inclusion (Month1 to Month5)
Demographics information
Time Frame: at inclusion (Month1 to Month5)
Demographics information will be obtained via a single questionnaire including questions on age, gender, qualification, personal work status, ethnicity, life and occupational events
at inclusion (Month1 to Month5)
Variation of health factors risks after the interventional phase
Time Frame: at inclusion (Month1 to Month5)
Evaluate the effectiveness of an individualized thermal intervention on health factors.
at inclusion (Month1 to Month5)
Variation of body composition after the interventional phase
Time Frame: at inclusion (Month1 to Month5)
Evaluate the effectiveness of an individualized thermal intervention on body composition.
at inclusion (Month1 to Month5)
Variation of subjective stress measures after the interventional phase
Time Frame: at inclusion (Month1 to Month5)
Evaluate the effectiveness of an individualized thermal intervention on subjective stress measures.
at inclusion (Month1 to Month5)
Variation of health biomarkers after the interventional phase
Time Frame: at inclusion (Month1 to Month5)
Evaluate the effectiveness of an individualized thermal intervention on Health-related risk assessed by biomarkers.
at inclusion (Month1 to Month5)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 1, 2017

Primary Completion (ANTICIPATED)

March 1, 2021

Study Completion (ANTICIPATED)

March 1, 2021

Study Registration Dates

First Submitted

March 26, 2018

First Submitted That Met QC Criteria

May 14, 2018

First Posted (ACTUAL)

May 24, 2018

Study Record Updates

Last Update Posted (ACTUAL)

May 24, 2018

Last Update Submitted That Met QC Criteria

May 14, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • CHU-386
  • 2016 A02082 49 (OTHER: 2016 A02082 49)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on 6 days spa residential program

3
Subscribe